Oragenics
OGEN
14 hedge funds and large institutions have $2.39M invested in Oragenics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
24% less capital invested
Capital invested by funds: $3.15M → $2.39M (-$764K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$72.2K |
| 2 |
VF
Virtu Financial
New York
|
+$31.2K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$17.8K |
| 4 |
Barclays
London,
United Kingdom
|
+$16.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$133K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |
OGEN Hedge Fund Activity: Q4 2019 in Review
14 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2019, worth a combined $2.39M — down 24% from $3.15M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $72.2K. The largest seller was Sabby Management, cutting an estimated $133K.
- 14 institutional investors held Oragenics (OGEN) as of Q4 2019, up from 13 in Q3 2019.
- Funds reported $2.39M of Oragenics stock for Q4 2019, down 24% quarter-over-quarter.
- 3 funds opened new Oragenics positions in Q4 2019 and 1 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q4 2019 was Renaissance Technologies, an estimated $72.2K added.
- The largest Oragenics seller in Q4 2019 was Sabby Management, an estimated $133K sold.
Based on aggregated 13F filings for Q4 2019.